Nice

News

NICE rejects Opdivo in head and neck cancer – before it gain...

England and Wales’ cost effectiveness watchdog NICE has rejected Opdivo for use against advanced head and neck cancer in draft guidance – before the drug has even been given final Euro

Views & Analysis

Social Media Social Networking Technology Connection Concept

How healthcare professionals engage NICE online

NICE is reaching out and engaging more via social media.

News

Hospitals should be fined for failing to innovate - report

Government must get tough to encourage innovation, say peers.

News

Charities unite to oppose NICE rare disease rules

MPs to discuss controversial plan in special debate.

News

NICE rejects Darzalex, citing lack of clinical evidence

NICE has rejected Janssen’s Darzalex (daratumumab) for regular NHS funding in third line multiple myeloma, saying that gaps in clinical evidence mean cost-effectiveness data are unreliable.

News

Government must rethink drug rationing plans - experts

The government looks set to come under pressure to rethink moves to ration access to medicines, after a new plan from NICE and NHS England was criticised by industry representatives and oth